Peer-Review Record
Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”
Vaccines 2023, 11(4), 807; https://doi.org/10.3390/vaccines11040807
by
Abhishek Royal 1
, Denny John 2, Omesh Bharti 3, Ritesh Tanwar 4, Deepak Kumar Bhagat 5, Retna Siwi Padmawati 1, Vishal Chaudhary 6, Reddicherla Umapathi 7, Pradeep Bhadola 8,* and Adi Utarini 1
, Denny John 2, Omesh Bharti 3, Ritesh Tanwar 4, Deepak Kumar Bhagat 5, Retna Siwi Padmawati 1, Vishal Chaudhary 6, Reddicherla Umapathi 7, Pradeep Bhadola 8,* and Adi Utarini 1Reviewer 1:
Vaccines 2023, 11(4), 807; https://doi.org/10.3390/vaccines11040807
Submission received: 27 March 2023
/
Accepted: 3 April 2023
/
Published: 6 April 2023
(This article belongs to the Special Issue Research in Vaccine Epidemiology: Immunogenicity, Effectiveness, and Safety)
Round 1
Reviewer 1 Report
In my opinion, the response on Kapur et al’s Comment on Royal et al. article deserves publication. This reply helps to further clarify some points of the article raised by Kapur's comment.
